Jacobs Levy Equity Management, Inc Vanda Pharmaceuticals Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,430,533 shares of VNDA stock, worth $6.69 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,430,533
Previous 1,486,262
3.75%
Holding current value
$6.69 Million
Previous $8.4 Million
20.1%
% of portfolio
0.03%
Previous 0.04%
Shares
24 transactions
Others Institutions Holding VNDA
# of Institutions
161Shares Held
45.2MCall Options Held
165KPut Options Held
33.6K-
Black Rock Inc. New York, NY8.14MShares$38.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.01MShares$18.8 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$17 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$11 Million0.94% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.26MShares$10.6 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $265M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...